Verrica Pharmaceuticals (VRCA) Receivables - Other (2022 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Receivables - Other of $46000.0 for Q1 2025, down 92.23% year-over-year from $592000.0 in Q1 2024, and up 58.62% quarter-over-quarter from $29000.0 in Q4 2024.
Verrica Pharmaceuticals (VRCA) Receivables - Other (2022 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Receivables - Other history runs 4 years deep, the most recent figure standing at $46000.0 for Q1 2025.
- In Q1 2025, Receivables - Other fell 92.23% year-over-year to $46000.0; the TTM figure through Mar 2025 stood at $46000.0 (down 92.23% YoY), while the FY2024 annual figure was $29000.0, down 82.74% from the prior year.
- Receivables - Other for Q1 2025 stood at $46000.0, up from $29000.0 in the prior quarter.
- The five-year high for Receivables - Other was $592000.0 in Q1 2024, with the low at $29000.0 in Q4 2024.
- The 4-year median for Receivables - Other is $168000.0 (2023), against an average of $201769.2.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other jumped 957.14% in 2024, then slumped 92.23% in 2025.
- Verrica Pharmaceuticals' Receivables - Other stood at $99000.0 in 2022, then jumped by 69.7% to $168000.0 in 2023, then slumped by 82.74% to $29000.0 in 2024, then jumped by 58.62% to $46000.0 in 2025.
- Business Quant data shows VRCA's Receivables - Other at $46000.0 in Q1 2025, $29000.0 in Q4 2024, and $84000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Verrica Pharmaceuticals | 102.80 Mn | 91.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.30 Mn |
| Jun 30, 2026 | 2.30 Mn |
| Mar 31, 2025 | 46,000.00 |
| Mar 31, 2025 | 46,000.00 |
| Dec 31, 2024 | 29,000.00 |
| Dec 31, 2024 | 29,000.00 |
| Sep 30, 2024 | 84,000.00 |
| Sep 30, 2024 | 84,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | 592,000.00 |
| Mar 31, 2024 | 592,000.00 |
| Dec 31, 2023 | 168,000.00 |
| Dec 31, 2023 | 168,000.00 |
| Sep 30, 2023 | 126,000.00 |
| Sep 30, 2023 | 126,000.00 |
| Jun 30, 2023 | 173,000.00 |
| Jun 30, 2023 | 173,000.00 |
| Mar 31, 2023 | 56,000.00 |
| Mar 31, 2023 | 56,000.00 |